Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04245800 · ClinicalTrials.gov registry record
Home Testing of Respiratory Illness
A clinical trial of Respiratory Tract Infections and Influenza a, sponsored by Evidation Health.
- Completed
- Registry status
- 5,233
- Enrollment target
- 1
- Study location
NCT04245800: Completed study of Respiratory Tract Infections and Influenza a, sponsored by Evidation Health.
NCT04245800 is a study of Respiratory Tract Infections and Influenza a that has completed, run by Evidation Health. The registered enrollment target is 5,233 participants, above the 2,426-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (116% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04245800, a study of Respiratory Tract Infections and Influenza a, has completed, sponsored by Evidation Health.
- COMPLETED
- Registry status
- 5,233 participants
- Enrollment target
- 1
- Study location
Study Summary
The main goal of this research study is to use data from activity trackers (such as Fitbits), lab tests, and surveys to see if activity, sleep, and heart rate data can tell the difference between when someone has a respiratory illness (e.g., flu) and when they are feeling healthy. The research will also study an investigational flu@home test and app. If successful, results from the study could be used in the future to better identify people with respiratory illness. In addition, this study will test the accuracy of an at-home flu test kit compared to laboratory test results.
Primary Outcome
Behavioral data from Fitbit wearables, patient self-reported data (includes but is not limited to demographics, symptoms, medical history, lifestyle, comorbidities, and Medical care utilization), and diagnostics during flu or RVI episode
Conditions Studied
Study Locations (1)
California
- Evidation Health - San Mateo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,233 participants |
| Start Date | 2019-12-13 |
| Est. Completion | 2020-07-06 |
What the finished NCT04245800 record still lists
NCT04245800 is an observational study that tracks outcomes without assigning an intervention. Its 5,233 participants enrollment target places it among the larger protocols in the corpus, above the 2,426-participant average among 15 other Respiratory Tract Infections trials with a reported enrollment target (116% higher).
The record links to 5 conditions, with Respiratory Tract Infections appearing as the primary indexed condition, and to 0 interventions.
NCT04245800 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04245800 about?
NCT04245800 is a clinical study titled "Home Testing of Respiratory Illness". The main goal of this research study is to use data from activity trackers (such as Fitbits), lab tests, and surveys to see if activity, sleep, and heart rate data can tell the difference between when someone has a respiratory illness (e.g., flu) and when they are feeling healthy. The research will ...
What is the current status of trial NCT04245800?
This trial is currently completed. The enrollment target is 5,233 participants. The study started on 2019-12-13. Estimated completion is 2020-07-06.
What conditions does trial NCT04245800 study?
This clinical trial studies the following conditions: Respiratory Tract Infections, Influenza a, Influenza-like Illness, Respiratory Viral Infection, Influenza Type B.
Who is sponsoring clinical trial NCT04245800?
This trial is sponsored by Evidation Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04245800 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04245800's enrollment target sits among peer trials
5,233 3rd of 15 higher than 13 of 15 other Respiratory Tract Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses
RECRUITING · NA
-
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
RECRUITING · NA
-
An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.
RECRUITING · NA
-
Beetroot Juice NO Cold Study
RECRUITING · Phase 2
-
Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly
ACTIVE NOT RECRUITING · Phase 2
-
A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06506344 · 5,250 participants · NA
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
- NCT05989308 · 5,200 participants · NA
MyChart Proxy Outreach to Parents (MyPOP)
- NCT06008197 · 5,200 participants · Phase 3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- NCT05135403 · 5,179 participants
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI